Goodwin

Contact
Share
Info
100 Northern Avenue
Boston, MA 02210, United States
Phone: 617.570.1000
Fax: 617.523.1231
Areas Of Practice
  • Antitrust & Trade Regulation
  • Appellate Practice
  • Art, Entertainment, & Sports Law
  • Class Action
  • Criminal Law
  • Energy & Utilities
  • Environmental Law
  • Finance & Banking
  • Government
  • Intellectual Property
  • International Law & Trade
  • Labor & Employment Law
  • Litigation
  • Privacy
  • Products Liability
  • Real Estate
  • Science, Computers, & Tech
  • Securities Law
  • Taxation
  • Toxic Torts
  • Transportation
  • Wills, Trusts, & Estate Planning
See more
Locations
Other U.S. Locations
  • California
  • D.C.
  • Massachusetts
  • New York
Other Countries
  • France
  • Germany
  • Hong Kong
  • United Kingdom
Number of Attorneys
1,000+ Attorneys

PISCES 101 - The Private Intermittent Securities and Capital Exchange System: What you need to know about the world’s first regulated exchange for the trading of shares in private companies.

What is PISCES?  The Private Intermittent Securities and Capital Exchange System (PISCES) is a UK government–backed initiative designed to enable private companies to offer and trade their existing shares in a controlled,… more
 /  Business Organizations, Securities Law

America’s AI Action Plan Emphasizes Governance and Risk Management to Promote the Secure and Safe Adoption of AI Tools

On July 23, 2025, the Trump Administration released its AI Action Plan (“the Plan”), a long-anticipated roadmap for the federal government’s approach to AI governance that presents a number of implications for businesses… more
 /  Government Contracting, International Law & Trade, Science, Computers, & Technology

California’s New Privacy and Cybersecurity Regulations on Risk Assessments, Automated Decision making and Cybersecurity Audits: What Businesses Need to Know

During a Board Meeting on July 24, 2025, the California Privacy Protection Agency (CPPA) unanimously approved the long-awaited final text of its second rulemaking package, implementing a broad swath of new requirements regarding… more
 /  Privacy, Science, Computers, & Technology

Carried Interest 2.0: Luxembourg Modernises Its Tax Treatment for Fund Managers

On 24 July 2025, a draft bill (the Bill) proposing significant amendments to the law of 4 December 1967 on income tax and the law of 12 July 2013 on alternative investment fund managers (AIFMs) was submitted to the Luxembourg… more
 /  Finance & Banking, Taxation

FinCEN to Postpone Effective Date and Reopen Anti-Money Laundering Rule for Investment Advisers

On July 21, 2025, the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) announced its intent to postpone the effective date of the Anti-Money Laundering/Countering the Financing of Terrorism Program… more
 /  Finance & Banking, Securities Law

Fresenius Files Two IPRs Against Regeneron Aflibercept Patents

On July 14, 2025 Fresenius filed two IPR petitions challenging Regeneron’s patents related to aflibercept. Regeneron has not asserted that Fresenius infringes either of these patents in district court litigation; however, there… more
 /  Intellectual Property, Science, Computers, & Technology

Harrow Enters Agreement to Commercialize Samsung Bioepis’s Ophthalmology Biosimilars Following Biogen’s Exit

On July 17, 2025, Harrow, Inc. (“Harrow”), announced an agreement with Samsung Bioepis Co. Ltd. (“Samsung Bioepis”) to acquire the U.S. commercial rights to two of Samsung Bioepis’s biosimilars, BYOOVIZ® (ranibizumab-nuna) and… more
 /  Commercial Law & Contracts, Science, Computers, & Technology

Biocon Regulatory Approval Updates in the U.S. and Europe: Insulin Aspart and Denosumab

On July 15, 2025, Biocon Biologics, a fully integrated global biosimilars company and a subsidiary of Biocon Ltd., announced that the FDA has approved KIRSTY (insulin aspart-xjhz injection), 100 units/mL, as the first and only… more
 /  Health, Science, Computers, & Technology

Bio-Thera Announces Acceptance of BLA for BAT2506 Referencing Johnson & Johnson’s SIMPONI® (Golimumab)

On July 16, 2025, Bio-Thera Solutions, Ltd. (“Bio-Thera”) announced that the U.S. Food and Drug Administration (“FDA”) had accepted its Biologics License Application (“BLA”) for its golimumab biosimilar, BAT2506, referencing… more
 /  Science, Computers, & Technology

CFPB Abandons Plan to Scrap State Notice Rule

On July 21, 2025, the CFPB announced that it was withdrawing its planned recission of Section 1082.1 of the Consumer Financial Protection Act (CFPA) implementing regulations, which contains procedures by which state officials… more
 /  Administrative Law, Consumer Protection, Finance & Banking

In Management Equity Repurchases, Who Determines Fair Market Value?

A majority of private equity firms prefer for their boards to value departing management’s equity, but approaches vary based on the applicable circumstances. When management equity holders leave a private equity-backed… more
 /  Business Organizations, Commercial Law & Contracts

CFPB Terminates Consent Order Against Credit Union

On July 21, 2025, the Consumer Financial Protection Bureau (CFPB) announced that it had terminated its October 2024 consent order with a Florida-based credit union… more
 /  Consumer Protection, Finance & Banking

Joint Ventures for Public REITs: Opportunities and Challenges

Joint venture structures continue to be an important tool for public real estate investment trusts (REITs), particularly in market environments where traditional capital-raising strategies may be challenging from a funds from… more
 /  Business Organizations, Real Estate - Commercial, Taxation

The Trump Administration AI Action Plan: Faster, Higher, Stronger

The Trump administration revealed its long awaited AI Action Plan (the plan) on July 23, ordering the federal government to accelerate the development of artificial intelligence (AI) in the United States and “remove red tape and… more
 /  Administrative Law, Antitrust & Trade Regulation, International Law & Trade, Science, Computers, & Technology

France and the new EU regulation on political advertising: the CNIL updates its doctrine ahead of the 2025 implementation

Online political advertising has become central to modern electoral campaigns. However, the growing lack of transparency, particularly regarding funding, targeting, and data processing practices, raises serious concerns about… more
 /  Communications & Media Law, Elections & Politics, International Law & Trade, Privacy
Showing 1-15 of 1000 Results
/
View per page
Page: of 67
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide